Cargando…
1567 Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782065/ http://dx.doi.org/10.1093/ofid/ofu052.1113 |
| _version_ | 1783295106645753856 |
|---|---|
| author | Cunningham, Douglas Shamblaw, David Zurawski, Christine Robbins, William Scarsella, Anthony Nguyen, Thai Hindman, Jason Ebrahimi, Ramin Piontkowsky, David |
| author_facet | Cunningham, Douglas Shamblaw, David Zurawski, Christine Robbins, William Scarsella, Anthony Nguyen, Thai Hindman, Jason Ebrahimi, Ramin Piontkowsky, David |
| author_sort | Cunningham, Douglas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5782065 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57820652018-03-01 1567 Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48 Cunningham, Douglas Shamblaw, David Zurawski, Christine Robbins, William Scarsella, Anthony Nguyen, Thai Hindman, Jason Ebrahimi, Ramin Piontkowsky, David Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5782065/ http://dx.doi.org/10.1093/ofid/ofu052.1113 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America |
| spellingShingle | IDWeek 2014 Abstracts Cunningham, Douglas Shamblaw, David Zurawski, Christine Robbins, William Scarsella, Anthony Nguyen, Thai Hindman, Jason Ebrahimi, Ramin Piontkowsky, David 1567 Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48 |
| title | 1567 Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48 |
| title_full | 1567 Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48 |
| title_fullStr | 1567 Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48 |
| title_full_unstemmed | 1567 Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48 |
| title_short | 1567 Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48 |
| title_sort | 1567 simplification to elvitegravir/cobicistat/emtricitabine/tenofovir df from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir df maintains hiv suppression and improves fasting triglycerides at week 48 |
| topic | IDWeek 2014 Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782065/ http://dx.doi.org/10.1093/ofid/ofu052.1113 |
| work_keys_str_mv | AT cunninghamdouglas 1567simplificationtoelvitegravircobicistatemtricitabinetenofovirdffromritonavirboostedproteaseinhibitorplusemtricitabinetenofovirdfmaintainshivsuppressionandimprovesfastingtriglyceridesatweek48 AT shamblawdavid 1567simplificationtoelvitegravircobicistatemtricitabinetenofovirdffromritonavirboostedproteaseinhibitorplusemtricitabinetenofovirdfmaintainshivsuppressionandimprovesfastingtriglyceridesatweek48 AT zurawskichristine 1567simplificationtoelvitegravircobicistatemtricitabinetenofovirdffromritonavirboostedproteaseinhibitorplusemtricitabinetenofovirdfmaintainshivsuppressionandimprovesfastingtriglyceridesatweek48 AT robbinswilliam 1567simplificationtoelvitegravircobicistatemtricitabinetenofovirdffromritonavirboostedproteaseinhibitorplusemtricitabinetenofovirdfmaintainshivsuppressionandimprovesfastingtriglyceridesatweek48 AT scarsellaanthony 1567simplificationtoelvitegravircobicistatemtricitabinetenofovirdffromritonavirboostedproteaseinhibitorplusemtricitabinetenofovirdfmaintainshivsuppressionandimprovesfastingtriglyceridesatweek48 AT nguyenthai 1567simplificationtoelvitegravircobicistatemtricitabinetenofovirdffromritonavirboostedproteaseinhibitorplusemtricitabinetenofovirdfmaintainshivsuppressionandimprovesfastingtriglyceridesatweek48 AT hindmanjason 1567simplificationtoelvitegravircobicistatemtricitabinetenofovirdffromritonavirboostedproteaseinhibitorplusemtricitabinetenofovirdfmaintainshivsuppressionandimprovesfastingtriglyceridesatweek48 AT ebrahimiramin 1567simplificationtoelvitegravircobicistatemtricitabinetenofovirdffromritonavirboostedproteaseinhibitorplusemtricitabinetenofovirdfmaintainshivsuppressionandimprovesfastingtriglyceridesatweek48 AT piontkowskydavid 1567simplificationtoelvitegravircobicistatemtricitabinetenofovirdffromritonavirboostedproteaseinhibitorplusemtricitabinetenofovirdfmaintainshivsuppressionandimprovesfastingtriglyceridesatweek48 |